Stockscreener 앱 받기
31.74
0.84%
-0.27
시장 영업 전:
34.23
2.49
+7.84%
Atricure Inc 주식(ATRC)의 최신 뉴스
Cryoablation Market Set to Witness Significant Growth by 2032 | - openPR.com
AtriCure Announces First Use of the AtriClip PRO-Mini® Device | - GuruFocus
AtriCure launches smaller device for heart surgery By Investing.com - Investing.com South Africa
AtriCure announces first use of newest AtriClip device - MassDevice
AtriCure Reports 1st Use of Newest AtriClip LAA Exclusion System - Medical Product Outsourcing
AtriCure launches smaller device for heart surgery - Investing.com Australia
AtriCure Announces First Use of the AtriClip PRO-Mini® Device - Yahoo Finance
Groundbreaking Miniature Cardiac Device Transforms LAA Management: AtriClip PRO-Mini Debuts - Stock Titan
Dayton’s stocks continue loss streak following election and now tariffs - The Business Journals
AtriCure Drops 25%: Bargain Or Caution Sign? (NASDAQ:ATRC) - Seeking Alpha
AtriCure to Announce First Quarter 2025 Financial Results - MarketScreener
Is AtriCure (NASDAQ:ATRC) A Risky Investment? - simplywall.st
JMP maintains AtriCure stock with $60 target post-Investor Day By Investing.com - Investing.com Canada
When the Price of (ATRC) Talks, People Listen - news.stocktradersdaily.com
Canaccord Genuity Adjusts Price Target on AtriCure to $52 From $66, Maintains Buy Rating - MarketScreener
Oppenheimer maintains AtriCure stock Outperform rating, $45 target By Investing.com - Investing.com Australia
UBS maintains Buy on AtriCure stock, reiterates $60 target By Investing.com - Investing.com Australia
UBS maintains Buy on AtriCure stock, reiterates $60 target - Investing.com
Piper Sandler maintains $50 target on AtriCure stock, cites growth By Investing.com - Investing.com Canada
Piper Sandler maintains $50 target on AtriCure stock, cites growth - Investing.com
Needham maintains Buy on AtriCure stock, $51 target By Investing.com - Investing.com Australia
Needham maintains Buy on AtriCure stock, $51 target - Investing.com
Oppenheimer maintains AtriCure stock Outperform rating, $45 target - Investing.com
BTIG raises AtriCure stock price target to $58, maintains buy By Investing.com - Investing.com South Africa
BTIG raises AtriCure stock price target to $58, maintains buy - Investing.com
AtriCure Highlights Growth and Innovation at Investor Day - TipRanks
Electrophysiology Devices Market Poised for Strong Growth, Projected to Expand at a 9.73% CAGR by 2030, Reports DelveInsight - Barchart.com
Needham maintains AtriCure stock Buy rating, $51 target By Investing.com - Investing.com Canada
11 Analysts Have This To Say About AtriCure - Benzinga
Needham maintains AtriCure stock Buy rating, $51 target - Investing.com India
(ATRC) Investment Analysis - news.stocktradersdaily.com
AtriCure to Host Analyst & Investor Day on March 26, 2025 - Yahoo Finance
AtriCure Investor Day: New Product Pipeline and Financial Targets Coming March 2025 - Stock Titan
AtriCure, Inc. to Host Earnings Call - ACCESS Newswire
AtriCure Independent Director Karen Prange Sells 25% Of Holding - Simply Wall St
(ATRC) Long Term Investment Analysis - Stock Traders Daily
AtriCure (NASDAQ:ATRC) Stock Price Down 6% Following Insider Selling - Defense World
Atricure director Karen Prange sells $232,531 in stock By Investing.com - Investing.com Canada
Atricure Director Makes a Significant Stock Sale! - TipRanks
3.50%
0.47%
자본화:
|
볼륨(24시간):